OUR PRODUCTS

MOBILE APPS

GENERAL INFO

AMLX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Amylyx Pharmaceuticals (AMLX) Earnings Date & Reports

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AMLX is expected to report earnings to fall 2.07% to -45 cents per share on November 06

Amylyx Pharmaceuticals AMLX Stock Earnings Reports

Q3'25

Est.

$-0.45

Q2'25

Est.

$-0.46

Q1'25

Beat

by $0.20

Q4'24

Beat

by $0.01

Q3'24

Missed

by $0.37

The last earnings report on August 07 showed earnings per share of -46 cents, meeting the estimate of -46 cents. With 40.10K shares outstanding, the current market capitalization sits at 681.24M.

View a ticker or compare two or three

Compare

AMLX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AMLX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AMLX showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

43 Thorndike Street

Phone

+1 617 682-0917

Employees

384

Web

https://www.amylyx.com